Sigilon Terminates Hemophilia A Project

Sigilon Terminates Hemophilia A Project
Dec 18, 2021 7:31am

Thanks to Dean Willett, Precision BioLogic Inc. for this heads-up. Dean alerts us to this press release [click] outlining Sigilon’s decision to terminate their hemophilia program. They were exploring the use of cell-based therapy and unfortunately were not successful. See the press release and Sigilon's home page both offer a clear description of this interesting therapeutic approach.

0 Comments

Thanks to Dean Willett, Precision BioLogic Inc. for this heads-up. Dean alerts us to this press release [click] outlining Sigilon’s decision to terminate their hemophilia program. They were exploring the use of cell-based therapy and unfortunately were not successful. See the press release and Sigilon's home page both offer a clear description of this interesting therapeutic approach.

Leave A Comment

You must be logged in to Comment - Sign In